Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response

Recruiting now

Conditions studied: Asthma (Diagnosis), COPD (Chronic Obstructive Pulmonary Disease)

In brief

This study aims to improve the diagnosis and treatment prediction of asthma and chronic obstructive pulmonary disease (COPD) by combining quantitative chest computed tomography (CT) imaging with multi-omics data. Adults with asthma or COPD will be enrolled and undergo routine clinical evaluations, pulmonary function tests, blood tests, and chest CT scans. Additional samples, such as sputum and microbiome specimens, may also be collected. No experimental drugs or devices will be administered as part of this study. Researchers will analyze CT imaging features together with clinical, laboratory, and biological data to better distinguish asthma from COPD and to identify factors that may predict treatment response. The findings are expected to contribute to more precise and personalized management of chronic airway diseases.

Key facts

Study ID
NCT07602192
Run by
Korea University Guro Hospital
People needed
200
Starts
2025-12-22
Expected to finish
2027-12-22
Last updated by the study team
2026-07-07

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.